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Signal transduction to nuclear factor-kappa B
(NF-kB) involves multiple kinases and phosphory-
lated target proteins, but little is known about
signal termination by dephosphorylation. By RNAi
screening, we have identified protein phosphatase
4 regulatory subunit 1 (PP4R1) as a negative regu-
lator of NF-kB activity in T lymphocytes. PP4R1
formed part of a distinct PP4 holoenzyme and
bridged the inhibitor of NF-kB kinase (IKK) complex
and the phosphatase PP4c, thereby directing PP4c
activity to dephosphorylate and inactivate the IKK
complex. PP4R1 expression was triggered upon
activation and proliferation of primary human T
lymphocytes and deficiency for PP4R1 caused
sustained and increased IKK activity, T cell hyperac-
tivation, and aberrant NF-kB signaling in NF-kB-
addicted T cell lymphomas. Collectively, our results
unravel PP4R1 as a previously unknown activation-
associated negative regulator of IKK activity in
lymphocyteswhose downregulation promotes onco-
genic NF-kB signaling in a subgroup of T cell
lymphomas.
INTRODUCTION
Signaling to nuclear factor-kappa B (NF-kB) is crucial for T
lymphocyte activation, differentiation, and proliferation by regu-
lating a wide variety of target genes such as different cytokines
(e.g., interleukin-2 [IL-2], interferon gamma [IFN-g], and tumor
necrosis factor alpha [TNF-a]), chemokines (e.g., IL-8), and anti-
apoptotic molecules (e.g., Bcl-2, c-IAPs) (Bonizzi and Karin,2004; Ghosh and Karin, 2002; Ruland and Mak, 2003a). NF-kB
activation in response to T cell receptor (TCR) or TNF receptor
1 (TNFR1) triggering is mediated by a high molecular weight
IkB kinase (IKK) complex (Ha¨cker and Karin, 2006; Hayden and
Ghosh, 2004). The IKK complex comprises two enzymatic
subunits, IKKa and IKKb, and the regulatory subunit IKKg
(NEMO) (Ha¨cker and Karin, 2006). IKK activation results in phos-
phorylation of inhibitory kBproteins, the IkBs, which interact with
NF-kB transcription factors and render them inactive within the
cytoplasm. Phosphorylated IkB proteins are rapidly ubiquitiny-
lated and targeted for proteasomal degradation. In turn, liber-
ated NF-kB proteins, like RelA (p65), translocate into the
nucleus, where they bind to and transactivate kB sites within
the promoter region of NF-kB-regulated genes (Hayden and
Ghosh, 2008; Vallabhapurapu and Karin, 2009).
IKK activation is a transient event that is subject to several
postinductive negative feedback mechanisms ensuring proper
signal shaping, control, and termination (Acuto et al., 2008).
Prominent examples are the ubiquitin-editing enzymes A20
and the cylindromatosis tumor suppressor (CYLD), which act
as negative regulatory control elements of NF-kB. Indeed,
defects in negative regulation by A20 in lymphocytes cause
enhanced and prolonged IKK phosphorylation, resulting in hy-
peractivation of cells and promoting lymphoid malignancies
(Du¨wel et al., 2009; Hymowitz and Wertz, 2010).
The NF-kB activating signal cascade in T lymphocytes
involvesmultiple phosphorylation events and relies on a complex
phosphoproteome (Ha¨cker and Karin, 2006; Weil and Israe¨l,
2006). Several kinases that control NF-kB activation have been
identified (Ha¨cker and Karin, 2006). By contrast, only a few phos-
phatases have been shown to regulate and terminate NF-kB
activity in a cell type-, pathway-, or substrate-specific fashion
(Chew et al., 2009; Eitelhuber et al., 2011; Li et al., 2006, 2008).
PP4R1 (protein phosphatase 4, regulatory subunit 1) was the
first noncatalytic, regulatory phosphatase subunit identified as
a constitutive interaction partner of the catalytic Ser-ThrImmunity 37, 697–708, October 19, 2012 ª2012 Elsevier Inc. 697
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IKK Suppression by PP4R1-Driven Dephosphorylationphosphatase subunit PP4c (Kloeker and Wadzinski, 1999).
PP4c is a ubiquitously expressed phosphatase that shares about
65% amino acid identity with PP2A catalytic subunits and
belongs to the PP2A-type phosphatases (Brewis et al., 1993).
Several PP4c-interacting proteins have been identified,
including PP4R1, PP4R2, PP4R3a, PP4R3b, and PP4R4, which
give rise to a diverse collection of distinct PP4 holoenzymes
(Chen et al., 2008; Chowdhury et al., 2008; Gingras et al.,
2005; Lee et al., 2010).
Given the crucial role of NF-kB in lymphocyte physiology, it is
not surprising that aberrant NF-kB activity has been implicated in
a number of lymphoid malignancies (Ruland and Mak, 2003b;
Skinnider and Mak, 2002). One very prominent example is cuta-
neous T cell lymphoma (CTCL), a subset of primarily skin-homing
non-Hodgkin’s lymphomas (NHLs), which show addiction to
constitutively activated NF-kB (Hwang et al., 2008). The majority
of CTCL are represented by the entities of Mycosis fungiodes
(MF; tumorous skin manifestation) and the more aggressive Se´z-
ary syndrome (SS; leukemic presentation), the latter of which can
arise secondarily from late-stage MF or as de novo SS (Herling
et al., 2004; Hwang et al., 2008). MF and SS are slowly progres-
sivemalignancies of clonally expandedCD4+ T lymphocytes that
are difficult to treat and usually incurable. Although several
components of the NF-kB signaling machinery have been previ-
ously identified as bona fide oncogenes or tumor suppressors in
lymphocytes (Compagno et al., 2009; Lenz et al., 2008; Staudt,
2010), the molecular lesions driving aberrant NF-kB signaling in
CTCL remain largely enigmatic (Kiessling et al., 2011; Kim
et al., 2000).
Here, we report the identification of PP4R1 by a small inter-
fering RNA (siRNA) screen as a negative regulator of TCR and
TNFR1-dependent NF-kB activity in T lymphocytes. PP4R1
expression was triggered by T cell activation and proliferation
but lost in CTCL. PP4R1 bound to the inhibitor of NF-kB kinases
(IKK)a and IKKb and the catalytic subunit PP4c and thereby
directed PP4c phosphatase activity to the IKK complex. Conse-
quently, PP4R1 silencing caused sustained and increased IKK
activity and T cell hyperactivation. Furthermore, deficiency for
PP4R1 in CTCL resulted in constitutive IKK-NF-kB signaling
and thus formed an important molecular event maintaining the
malignant phenotype of a subset of CTCL cells. Our findings
show that PP4R1 is a regulator of IKK activity and a suppressor
of oncogenic NF-kB signaling in a subgroup of T cell lymphomas.
RESULTS
RNAi Screen Identifies PP4R1 as a Regulator of NF-kB
To systematically uncover phosphatases that are involved in the
regulation of NF-kB signaling in T lymphocytes, we performed an
RNAi-based screen using a subgenomic siRNA library. There-
fore, we engineered a Jurkat reporter T cell line that secretes
Gaussia luciferase in an NF-kB-dependent fashion (G-Luc
Jurkat; see Figures S1A–S1F available online). Primary RNAi
screening identified two PP4R1-targeting siRNAs that
augmented NF-kB reporter activity in response to TCR and to
TNFR1 stimulation (Figure 1A; Tables S1 and S2). In Jurkat
T cells, various independent siRNAs against PP4R1 led to
a detectable knockdown of PP4R1 and enhanced PMA+
ionomycin-induced upregulation and secretion of several698 Immunity 37, 697–708, October 19, 2012 ª2012 Elsevier Inc.NF-kB-regulated cytokines (Figure 1B; Figures S1G–S1L).
Knockdown of PP4R1 elevated TCR+CD28-induced (Figure 1C)
or PMA- or TNFR1-induced (Figure 1D) NF-kB reporter activity
similarly to knockdown of the known negative regulator CYLD.
Furthermore, PP4R1 silencing enhanced expression of the
NF-kB target genes A20 and IkBa (data not shown) and of IL-2
and IL-8 (Figure 1E). The fact that PP4R1 impinges upon both
TCR- and TNFR1-induced NF-kB signaling indicated that
PP4R1 acts on a common level in canonical NF-kB signaling in
T lymphocytes.
PP4R1 Expression Is Triggered by Lymphocyte
Activation and Expansion In Vitro
To evaluate the physiological relevance of our findings, wemoni-
tored PP4R1 expression in primary human peripheral blood T
lymphocytes. Surprisingly, PP4R1 was not detectable in resting
T cells. However, PP4R1 expression increased upon T cell acti-
vation and in vitro proliferation, whereas the expression of the
PP4 catalytic subunit PP4c remained constant (Figure 2A). The
activation-associated pattern of PP4R1 expression in human T
lymphocytes was highly reproducible and equally observed for
T cells that had been prestimulated in vitro either by the poly-
clonal mitogen PHA or by CD3+CD28 crosslinking using
agonistic antibodies (Figure 2B).
PP4R1 expression generally followed a pattern of lymphocyte
activation and differentiation. In fact, we observed a strong
PP4R1 positivity for activated centroblastoid B cells (Figures
S2A and S2B) and interfollicular T cells (Figures S2C and S2D)
in lymph node biopsies, whereas intrafollicular and perifollicular
T cells lacked PP4R1 expression (Figures S2F–S2L). As
observed in Jurkat T cells, PP4R1 knockdown in prestimulated,
expanded human T lymphocytes increased secretion of the
NF-kB-dependent cytokines IL-2, TNF-a, and IFN-g (Figure 2C).
Accordingly, knockdown of PP4R1 in prestimulated, expanded
human T lymphocytes drastically increased both basal and stim-
ulation-dependent NF-kB activity (Figure 2D), whereas ectopic
PP4R1 almost completely blunted NF-kB activation in T cells
(Figure 2E).
PP4R1 Specifically Suppresses NF-kB Activation
To achieve sustained gene silencing, we generated Jurkat T cells
stably expressing small hairpin RNAs (shRNAs) targeting PP4R1
(Figure S3A) and tested these cells for NF-kB, AP-1, and NF-AT
signaling by transient transfection of reporter genes. As ex-
pected, NF-kB activation was significantly elevated in PP4R1-
silenced cells, whereas AP-1 and NF-AT activation remained
unaffected (Figure 3A; Figure S3B). Importantly, enhanced
NF-kB activation of stably PP4R1-silenced cells was lost when
PP4R1 expression was transiently reconstituted (Figure 3B).
Moreover, exogenous PP4R1 decreased both basal and TCR+
CD28-induced NF-kB activity (Figures 3B and 3C, left), whereas
AP-1 andNF-AT activationwere not altered by overexpression of
PP4R1 (Figure 3C). In addition, suppression of TCR+CD28-
dependent NF-kB activation by ectopically expressed PP4R1
occurred in a dose-dependent manner (Figure S3C). In line
with these findings, stably PP4R1-silenced Jurkat T cells dis-
played enhanced PMA+ionomycin-triggered expression of
multiple NF-kB target genes (Figure 3D) and increased secretion
of IL-2, IL-8, and IFN-g upon stimulation (Figure 3E; Figure S3D).
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B Figure 1. Identification of PP4R1 as a Nega-
tive Regulator of NF-kB
(A) Results of the phosphatasome-targeting siRNA
screen depicted as Z score distribution for indi-
vidual phosphatase-specific siRNAs and control
siRNAs. Mean Z scores for PP4R1 siRNAs were
3.6; 2.1; 0.5.
(B) Independent siRNAs directed against PP4R1
(#1 to #7) were used to knock down PP4R1 in
Jurkat T cells. Secretion of IFN-g upon stimulation
by PMA+ionomycin was analyzed by ELISA.
Knockdown of PP4R1 is shown for selected
siRNAs (inset).
(C and D) Reporter cells were transfected with
nontargeting siRNA (siCtrl) or siRNAs targeting
PP4R1, CYLD, or RelA. TCR+CD28-, PMA- or
TNF-R1-induced NF-kB-dependent reporter
activities are shown. Expression of PP4R1 was
analyzed by immunoblotting (IB). *p = 0.0153 and
0.0195 for PMA and *p = 0.0197 and 0.0419 for
TNF-a, respectively. Asterisks indicate statistical
significance relative to control cells with *p < 0.05,
**p < 0.001, ***p < 0.0001.
(E) TCR+CD28-dependent IL-2 and IL-8 tran-
scription of Jurkat T cells is shown in the presence
or absence of PP4R1. Results of (B)–(E) rep-
resent at least two independent experiments. Data
are presented as mean ± SD of triplicate
measurements.
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suppresses NF-kB signaling in T cells.
PP4R1 Interacts with IKKa/b and PP4c
The fact that PP4R1 attenuates both TCR- and TNFR1-induced
NF-kB signaling suggested that PP4R1 operates on a common
level within the canonical NF-kB pathway. A central point of
convergence in canonical NF-kB signaling is the heterotrimeric
NEMO-dependent IKK complex (Hayden and Ghosh, 2008). To
investigate whether PP4R1 targets the IKK complex, we first
tested for a potential physical interaction between both compo-
nents. Indeed, we found coprecipitation of endogenous PP4R1
with the IKK complex following anti-IKKg (NEMO) immunopre-
cipitation in Jurkat T cells and prestimulated, primary human
T cells (Figures 4A and 4B). The IKK-specific association of
PP4R1 peaked at around 45 min after TCR+CD28 stimulation
and thereby sharply followed the peak of IKK phosphorylation
(Figure 4A). To further analyze which components of the IKK
complex, IKKa, IKKb, or IKKg (NEMO), interact with PP4R1,
we used expression of tagged proteins in HEK293T cells. WeImmunity 37, 697–708,found a specific interaction of hemagglu-
tinin (HA)-tagged PP4R1 only with FLAG-
tagged IKKa or IKKb but only a minor
association with the structural subunit
NEMO—most likely due to complex
formation between exogenous NEMO
and endogenous IKKa or IKKb (Figure 4C;
Figure S4A). The use of in vitro translated
proteins confirmed this result (Figure S4B)
and suggested a direct interaction of
PP4R1 with IKKa and IKKb, respectively.PP4R1 lacks intrinsic phospholytic activity but has been re-
ported to interact with the human PP4 catalytic subunit PP4c
(Chen et al., 2008; Gingras et al., 2005; Kloeker and Wadzinski,
1999). We confirmed stable complex formation between
PP4R1 and PP4c in HEK293T cells (Figure 4D) and further
demonstrated a stable interaction between endogenous pro-
teins in Jurkat T cells as well as in primary human T cells but
no binding of the structurally related phosphatase PP2Ac
(Figures S4C and S4D). The interaction between PP4R1 and
PP4cwas constitutive and did not change upon TCR stimulation.
The dual binding of PP4R1 to PP4c or IKKs prompted us to
investigate whether PP4R1-bound PP4c similarly associates
with the IKK complex. Indeed, similar to PP4R1, we found
PP4c to preassociate with the endogenous IKK complex in
Jurkat T cells (Figure 4E; Figure S4E). Several distinct PP4
modules with different regulatory subunits have been described
(Brewis et al., 1993; Chen et al., 2008; Chowdhury et al., 2008;
Lee et al., 2010; Zhang et al., 2005) and give rise to the possibility
that PP4R1 selectively directs PP4c toward the IKK complex. To
further substantiate this assumption, we used PP4R1-silencedOctober 19, 2012 ª2012 Elsevier Inc. 699
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Figure 2. PP4R1 Expression Is Triggered
upon Primary T Cell Expansion
(A and B) Primary human T lymphocytes were
activated and expanded. Expression of PP4R1
was determined by immunoblotting (IB) and rela-
tive protein levels were quantified by densitom-
etry. Expression of catalytic subunits PP4c and
PP1c and actin are shown for comparison (A).
Graphical representation of PP4R1 protein
expression in primary human T lymphocytes (n =
6) upon activation with anti-CD3/CD28 for 2 or
6 days relative to activation with PHA for 6 days is
shown. Bars indicate median values.
(C) Activated primary human T lymphocytes were
transfected with the indicated siRNAs. Secretion
of IL-2, TNF-a, and IFN-gwas measured by ELISA
upon TCR/CD28 stimulation. PP4R1 expression
was determined by IB.
(D) Activated CD4+ T cells were transfected with
the indicated siRNAs together with NF-kB reporter
plasmids, andNF-kBactivitywasmeasured3days
posttransfection. ***p = 0.0001 and p < 0.00001 for
unstimulated, **p = 0.0017 and ***p < 0.00001 for
anti-CD3/28, and ***p < 0.00001 for PMA/Iono.
(E) Activated CD4+ T cells (day 2 of expansion)
were transfected with NF-kB reporter plasmids
with or without PP4R1 expression vectors, and
NF-kB reporter activity was determined. Results
are shown as fold induction relative to empty
vector-transfected cells. Expression of exoge-
nous PP4R1 was analyzed by IB. Asterisks indi-
cate statistical significance relative to control cells
with *p < 0.05, **p < 0.001, ***p < 0.0001. ***p =
0.0009 for anti-CD3/28 and ***p = 0.0006 or PMA/
Iono. Results represent at least three (C) or two (D
and E) independent experiments. Data are pre-
sented as mean ± SD of triplicate measurements.
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Absence of PP4R1 abrogated basal and stimulation-induced
IKK-association of PP4c (Figure 4F), which confirms that
PP4R1 directs the IKK-specific localization of PP4c in T cells.
Furthermore, we could not observe any interaction between re-
combinant PP4R1 or PP4c with RelA (Figure S4F).
In accordance with the existence of several distinct PP4c
holoenzymes, PP4c was found to be localized both in the
nucleus and cytosol, whereas PP4R1 was predominantly
confined to the cytosolic compartment (Figure S4G).
Partial disruption of PP2A homologous heat repeats (Chen
et al., 2008; Kloeker and Wadzinski, 1999) within PP4R1 pre-
vented binding of PP4R1 to PP4c and partially abolished binding
to IKKa and IKKb (Figure 4G; Figures S4H and S4I), suggesting
a multimeric PP4R1-dependent complex with distinct interfaces
between PP4R1 and PP4c and IKKa and IKKb, respectively.
PP4R1 truncation mutants failed to suppress NF-kB activation
(Figures S4J–S4L), demonstrating that binding of PP4R1 to
PP4c is mandatory for PP4R1-mediated NF-kB suppression.700 Immunity 37, 697–708, October 19, 2012 ª2012 Elsevier Inc.PP4R1 Suppresses IKK/NF-kB
Activation
Our data suggest that PP4R1 selectively
directs PP4c phosphatase activity
toward the IKK complex to catalyze IKKdephosphorylation and inactivation. To further address this
point, we analyzed activation loop phosphorylation of IKKa and
IKKb in PP4R1-deficient compared to control-transfected cells.
We observed increased and sustained IKK phosphorylation,
which peaked 25 min after TCR+CD28 stimulation (Figure 5A).
Of note, PP4R1 did not affect phosphorylation of ERK1 or
ERK2 (Figures 5A and 5B). Next we directly measured kinase
activity of the endogenous IKK complex in the presence or
absence of PP4R1. TCR+CD28- or PMA+ionomycin-induced
IKK (auto-) phosphorylation as well as phosphorylation of its re-
combinant substrate GST:IkBa were strongly enhanced and
prolonged in PP4R1-silenced Jurkat T cells (Figures 5B and
5C; Figures S5A and S5B). We further investigated PP4R1-
mediated inhibition of IKK activity in a reverse experiment by co-
expression of HA:PP4R1 and FLAG:IKKb in Jurkat T cells.
Ectopic PP4R1 profoundly suppressed TCR+CD28-induced
IKKb kinase activity (Figure S5C). Consistent with increased
IKK phosphorylation, PP4R1-silenced cells displayed a more
rapid, enhanced, and sustained nuclear translocation of p65
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Figure 3. PP4R1 Is a Pathway-Specific Negative Regulator of NF-kB target Genes in T Cells
(A) Normalized activity of NF-kB-, AP-1-, or NF-AT-specific reporter genes upon TCR/CD28 or PMA/ionomycin stimulation in Jurkat T cells stably expressing
PP4R1 shRNA (shPP4R1#65) or nontargeting control shRNA (shCtrl). *p = 0.043 for anti-CD3/28 and ***p = 0.0007 or PMA/Iono. Asterisks indicate statistical
significance relative to control cells with *p < 0.05, **p < 0.001, ***p < 0.0001.
(B) TCR/CD28-dependent NF-kB reporter activity of Jurkat T cells stably expressing shPP4R1 or shCtrl with or without ectopic expression of PP4R1.
(C) Jurkat T cells transiently overexpressing HA-tagged PP4R1 were stimulated as indicated, and NF-kB-, AP-1-, or NF-AT-specific luciferase activity was
measured. Expression of exogenous PP4R1 was analyzed by IB.
(D) Gene expression in shPP4R1 compared to shCtrl Jurkat T cells upon PMA/ionomycin stimulation (1 hr) was examined by a qPCR gene expression array.
(E) IL-2 and IL-8 secretion of Jurkat T cells stably expressing shPP4R1#63, #65, or shCtrl upon TCR/CD28 stimulation. Results represent at least three inde-
pendent experiments. Data are presented as mean ± SD of duplicate (A–C) or triplicate (D–E) measurements. *p = 0.036, 0.032, 0.012 and 0.012 for IL-2; **p =
0.005, 0.003, 0.0057 and 0.0053 for IL-8, and, *p = 0.017 and **p = 0.002 for INF-g, respectively.
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induced by dominant active IKKb (IKKbSS/IKKbEE) (Mercurio
et al., 1997) or by overexpression of RelA, whereas IKKb
wild-type (WT)- or Carma1-mediated NF-kB activity were largely
abrogated (Figure 5D), implying that PP4R1 directly controls
activation loop dephosphorylation of IKKb. In line with a direct
role of PP4R1 in controlling the dephosphorylation of the IKK
complex, PMA+ionomycin-induced interaction of the signaladaptor proteins Carma1 and Bcl10 was not altered by
silencing of PP4R1 expression (Figure 5E). Moreover, ectopic
expression of PP4R1 in epithelial cells did equally suppress
PMA- as well as TNF- or IL-1-triggered NF-kB activation (Fig-
ure 5F). In concert, these results provide evidence for PP4R1
as a generic and direct negative regulator of IKK activity that
may operate in different receptor systems in lymphoid and non-
lymphoid cells.Immunity 37, 697–708, October 19, 2012 ª2012 Elsevier Inc. 701
A B C
D E F G
Figure 4. PP4R1 Recruits PP4c to the IKK Complex
(A and B) Jurkat T cells (A) or activated primary human T lymphocytes (B) were stimulated via the TCR or were left unstimulated. The IKK complex was
immunoprecipitated using anti-NEMO antibodies, and copurified PP4R1 was detected by IB. Filled and open arrowheads indicate specific proteins and IgG
heavy chain (IgGH), respectively. Results are representative of at least three independent experiments.
(C) HA-tagged PP4R1 was overexpressed in HEK293T cells alone or in combination with FLAG-tagged versions of IKKa, IKKb, or NEMO. Exogenous proteins
were immunoprecipitated using anti-HA antibodies.
(D) HA-tagged PP4R1 was overexpressed in HEK293T cells alone or in combination with FLAG-tagged PP4c. Tagged proteins were immunoprecipitated using
the indicated antibodies.
(E and F) PP4R1 or the IKK complex were immunoprecipitated from parental Jurkat T cells (E) or from Jurkat T cells stably expressing control shRNA (shCtrl) or
PP4R1-specific shRNA (shPP4R1) (F) using the indicated antibodies, and copurified proteins were detected by IB. Results are representative of at least two
independent experiments.
(G) FLAG:IKKa and FLAG:IKKbwas overexpressed in HEK293T cells together withWT or truncation mutants of HA:PP4R1. HA immunoprecipitations and lysates
were immunoblotted using indicated antibodies.
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Next, we asked whether dephosphorylation of IKKa and IKKb
involves both PP4R1 and the enzymatic activity of PP4c. There-
fore, we established a phosphatase activity assay using re-
combinant proteins. Concomitant expression of PP4R1 and
PP4c caused a synergistic increase in phosphatase activity (Fig-
ure 6A). Furthermore, we observed a strong but transient
increase in PP4R1-associated phosphatase activity in Jurkat
T cells and primary T lymphocytes upon TCR+CD28 stimulation
(Figures S6A and S6B). Expression of increasing amounts of
PP4R1 together with PP4c, but not of PP4R1 or PP4c alone,
completely blunted IKK phosphorylation on S180, 181 and
S176, 177 (Figure 6B; Figure S6C). This cooperative PP4R1-
dependent effect was most pronounced for PP4c because co-
overexpression of either PP2Ac or PP1c together with PP4R1
reduced IKK phosphorylation less efficiently than concomitant
expression of PP4R1 and PP4c (Figure S6D). Moreover,
PP4R1-PP4c-dependent dephosphorylation was highly specific
for IKKa and IKKb as phosphosubstrates because phosphoryla-
tion of RelA was not affected (Figure 6C). Importantly, all PP4R1
truncation mutants—that do not interact with endogenous
PP4c—failed to mediate IKK dephosphorylation (Figure 6D).702 Immunity 37, 697–708, October 19, 2012 ª2012 Elsevier Inc.Vice versa, overexpression of a dominant-negative catalytically
inactive mutant of PP4c was sufficient to overcome PP4R1-
mediated IKK dephosphorylation (Figure 6E), again proving
that PP4R1/PP4c forms an inseparable functional unit in coun-
terbalancing IKK-NF-kB signaling. In further support of this
assumption, stimulation-induced NF-kB activity in PP4R1-
silenced Jurkat cells was not increased by administration of
ocadaic acid (OA), a potent inhibitor of PP2A-like phosphatases,
whereas in control-transduced cells, stimulation-dependent
NF-kB activity increased in a dose-dependent manner (Fig-
ure 6F). These data indicate that the well-established effect of
OA on NF-kB signaling is based, at least in part, on inhibition
of the PP4R1/PP4c holoenzyme in T cells. To finally test for
a direct dephosphorylation of IKKa and IKKb by PP4R1/PP4c,
we purified phosphorylated IKK proteins and subjected them
as substrates to an in vitro phosphatase assay. Again, presence
of recombinant PP4R1 or PP4c led to dephosphorylation of
IKKa and IKKb (Figure S6E), indicating that IKK proteins
serve as direct substrates of the PP4R1/PP4c phosphatase
complex. Collectively, these results demonstrate that (1)
PP4R1 potentiates PP4c phosphatase activity, (2) PP4R1 directs
PP4c to specifically dephosphorylate the IKK complex, and (3)
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Figure 5. PP4R1 Negatively Regulates IKK Complex Activation in T Cells by Governing IKK Dephosphorylation
(A and B) Immunoblotting (IB) of lysates from siCtrl or siPP4R1-transfected (A) or stably silenced Jurkat T cells (B) stimulated with anti-CD3+CD28 antibodies
(0.5 mg/ml) or PMA+ionomycin. Endogenous IKK activities of shRNA expressing Jurkat T cells were determined by NEMO-immunoprecipitation and in vitro
kinase assay (KA).
(C) Phosphorylation of endogenous IKKa and IKKb was quantified using total IKK levels for normalization.
(D) HEK293T cells were transfected with the indicated expression vectors and NF-kB activity was measured. *p = 0.038 and ***p = 0.0009.
(E) PP4R1-targeting or control shRNA expressing Jurkat T cells were stimulated with PMA/ionomycin and anti-Bcl10 immunoprecipitations were IB using the
indicated antibodies. Filled and open arrowheads depict specific proteins and IgG heavy or light chains (IgGH/L), respectively.
(F) HEK293T cells with or without ectopic PP4R1 were stimulated as indicated and NF-kB activity was measured. **p = 0.003 and *p = 0.015 or 0.028 for PMA or
IL-1, respectively. Asterisks indicate statistical significance relative to control cells with *p < 0.05, **p < 0.001, ***p < 0.0001. Data are presented as mean ± SD of
triplicate measurements.
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TCR stimulation.
CTCL Cells Lack PP4R1
Constitutive NF-kBactivity is central in the survival of CTCL cells,
and besides a skin homing-phenotype, CTCL tumor cells exhibit
a strongly activated gene expression signature (i.e., HLA-DR,
CD25, IFN-g) in a site and stage-dependent manner (Swerdlow
et al., 2008). Thus, we asked whether dysregulation of NF-kB in
these cells correlates with reduced PP4R1 levels. Indeed, we
found significant downregulation of PP4R1 transcription as well
as protein expression in primary tumor cells derived from
peripheral blood of CTCL patients (Figure 7A; Figures S7A and
S7B). Moreover and in contrast to reactive nonmalignant T cells
in lymph node biopsies (Figures S2C and S2D) and in skin
biopsies from psoriasis patients (Figure 7B, top panel), lack of
PP4R1 expression was also observed for subepidermal, skin-
infiltrating tumor cells in diagnostic biopsies from eight CTCLpatients, with generally lower PP4R1 expression in the four SS
patients compared to the four MF patients (Figure 7B, bottom
panel; Table S3). We also observed defective PP4R1 expression
in the two CTCL cell lines Hut78 and HH, both originating from
primary Se´zary cells (Figure 7C; Figure S7C). Strikingly, HH cells
completely lacked PP4R1 expression, whereas Hut78 cells
showed reduced PP4R1 expression. Moreover, these cell lines
exhibited a specific NF-kB target gene expression signature
that was most pronounced for PP4R1-deficient HH cells
compared to Jurkat T cells (Figure 7D; Table S4). Given constitu-
tive NF-kB signaling, we next analyzed basal IKK activity in
multiple CTCL cell lines and found that loss of PP4R1 expression
in HH cells correlated with constitutive IKKb kinase activity (Fig-
ure 7E), as well as with constitutive IKK and IkBa phosphoryla-
tion, respectively (Figure 7F). Forced PP4R1 re-expression in
HHcells reversed IKKactivation and constitutiveNF-kBsignaling
(Figure 7G; Figure S7D), suggesting that PP4R1 deficiency is
a causative factor for constitutive IKK activation in these cells.Immunity 37, 697–708, October 19, 2012 ª2012 Elsevier Inc. 703
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Figure 6. PP4R1 and PP4c Cooperate to Catalyze IKK Dephosphorylation
(A) HA-tagged versions of PP4R1 or PP4c were overexpressed in HEK293T cells alone or in combination. Exogenous proteins were pulled down by anti-HA
antibodies and subjected to a colorimetric phosphatase activity assay.
(B) FLAG:IKKb was overexpressed in HEK293T cells together with increasing amounts of HA:PP4R1 and/or HA:PP4c. FLAG:IKKb was pulled down from whole-
cell lysates by anti-FLAG immunoprecipitation, and IKKb phosphorylation was assessed by IB.
(C) FLAG:IKKa and FLAG:IKKb or Flag:RelA were coexpressed with HA:PP4R1 or HA:PP4C separately or in combination, and FLAG immunoprecipitations and
lysates were immunoblotted using the indicated antibodies.
(D and E) FLAG:IKKa and FLAG:IKKb were overexpressed in HEK293T cells together with WT truncation mutants of HA:PP4R1 (E) or a phosphatase-inactive
double point mutant of PP4c (E). FLAG immunoprecipitations and lysates were immunoblotted using indicated antibodies.
(F) Jurkat T cells stably expressing control shRNA (shCtrl) or PP4R1-specific shRNA (shPP4R1) were treated with increasing amounts of ocadaic acid. Cells were
stimulated for 5 hr with PMA and ionomycin and NF-kB activity wasmeasured. **p = 0.0016, ***p = 0.0003 and **p = 0.0277 for 0, 25 and 50 nM, respectively. Data
are presented as mean ± SD of triplicate measurements.
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nant phenotype of CTCL cells, we cloned the complementary
DNA (cDNA) of PP4R1 into a GFP-coexpressing retroviral vector
to transduce four different CTCL cell lines. In contrast to PP4R1-
sufficient SeAx and MyLa cells, the abundance of positively
transduced Hut78 and most prominently HH cells was dramati-
cally decreased by forced expression of exogenous PP4R1 (Fig-
ure 7H; Figure S7E). This effect was highly specific for PP4R1
expression because overexpression of PP2Ac or PP4c did not
impact relative cell abundance. Thus, PP4R1 downregulation
in CTCL favors constitutive IKK activity and forms an oncogenic
condition promoting and/or maintaining the malignant pheno-
type of a subset of CTCL cells.
DISCUSSION
Multiple kinases and phosphorylated target proteins that induce
NF-kB activity have been identified. However, the molecular704 Immunity 37, 697–708, October 19, 2012 ª2012 Elsevier Inc.machinery involved in the termination of antigen receptor-medi-
ated NF-kB activation is only partially understood. Because
signal transduction from activated antigen receptors to NF-kB
largely relies on phosphorylation events (Hayden and Ghosh,
2004; Ruland and Mak, 2003b), it is generally assumed that
phosphatases play a major role in the modulation and termina-
tion of NF-kB activity.
The IKK complex forms a central signaling hub in canonical
NF-kB signaling that couples and integrates various receptor
signals to induce NF-kB transcriptional activity (Ha¨cker and
Karin, 2006). Here we provide several lines of evidence that
the PP4R1-PP4c phosphatase complex is a direct negative
regulator of IKK phosphorylation and activation in T cells. (1)
PP4R1 physically interacts with the native IKK complex in acti-
vated T lymphocytes, and this association increases following
IKK activation. (2) Knockdown of PP4R1 enhances and
prolongs IKK activation, whereas ectopic PP4R1 largely abro-
gates IKKb kinase activity. Conversely, enhanced basal and
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Figure 7. Reconstitution of PP4R1 Expression Attenuates the Malignant Phenotype of NF-kB-Addicted CTCL Cells
(A) IB of lysates from primary CD4+ T cells from peripheral blood of Se´zary patients with high tumor burden (#114–#120) and T cells from normal healthy donors
(#1–#5), both activated via anti-CD3/CD28 stimulation.
(B) PP4R1 expression, strongly present in activated T cells of psoriatic skin lesions (top panel), is lost in malignant T cells of CTCL (bottom panel). Representative
immunohistochemistry of skin biopsies from a total of five psoriasis patients and eight CTCL patients with MF and SS as single stains; red (AP) for CD3, CD25,
CD69, and brown (DAB) for PP4R1. ‘‘*’’ marks the epidermal papillae (sequential sections) included for better navigation of the enlarged areas.
(C) Expression of PP2Ac and PP4R1 in various CTCL cell lines were determined by qPCR. Levels are shown as fold change relative to Jurkat T cells.
(D) Basal messenger RNA expression levels of various NF-kB target genes were examined using a qPCR gene expression array. Expression is shown in
comparison to Jurkat T cells. Decreased and increased expression levels are depicted in green and red, respectively.
(E and F) NF-kB activity was assayed by a kinase assay (KA) for IKKb as in Figure 5 (E) or by phosphospecific antibodies directed against IKKa and IKKb or IkBa
(F). An isotype-matched antibody was included as control.
(G) FLAG:IKKb was transiently expressed in HH cells alone or together with HA:PP4R1. Kinase activity of IKKb and expression of HA:PP4R1 was determined as
before. Filled and open arrowheads indicate specific proteins and IgG heavy chain (IgGH), respectively. The asterisk indicates unspecific bands.
(H) Indicated CTCL cell lines were retrovirally transduced with expression vectors encoding for PP4R1, PP4c, or PP2Ac. Frequency of transduced cells was
monitored over time based on IRES-driven coexpression of GFP. Percentage of GFP-positive cells was normalized to that of control-transduced cells. The
experiments were conducted three times with similar outcome.
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IKK Suppression by PP4R1-Driven Dephosphorylationinduced IKK hyperactivation in PP4R1-silenced T cells or
PP4R1-deficient CTCL cells was rescued by re-expression of
ectopic PP4R1. Although PP4R1-silenced cells display already
increased basal IKK phosphorylation and NF-kB activity,
PP4R1 seems to be primarily involved in the shutdown of
stimulation-dependent IKK phosphorylation and kinase activity.
(3) PP4R1 recruits the catalytic subunit PP4c to the IKK
complex, and absence of PP4R1 prevents association of
PP4c and IKK proteins. (4) The PP4R1-PP4c complex mediates
dephosphorylation of activation loop serine residues within
IKKa and IKKb in vitro, and PP4R1-associated phosphatase
activity further increases upon TCR+CD28 stimulation following
the peak of IKK activity. (5) Constitutively active IKKb (IKKbSS/
IKKbEE) was sufficient to bypass PP4R1-mediated NF-kB inhi-
bition, and PP4R1 deficiency had no effect on CBM complex
assembly upstream of IKK activation, as well as on MAPK acti-
vation. In addition, PP4R1-silencing caused enhanced NF-kB
activity in response to TCR/CD28, PMA, or TNF-R1 stimulation.
In conclusion, PP4R1 is a regulator of canonical NF-kBsignaling, which directly acts on the level of the IKK complex
in T cells.
We have shown that PP4R1 is upregulated in proliferating and
prestimulated T cells, indicating a molecular mechanism of acti-
vation-induced feedback inhibition limiting T cell activation upon
TCR restimulation. The physiological relevance of this finding
was demonstrated by enhanced cytokine secretion of primed
T cells lacking PP4R1, whereas, conversely, ectopic PP4R1
blunted basal and stimulation-dependent NF-kB activity in ex-
panding T lymphocytes in vitro. The fact that resting T cells
lack PP4R1 expression, however, already suggests alternative
mechanisms of IKK control and dephosphorylation in T lympho-
cytes. Nonetheless, it is tempting to speculate that—through
differential expression of phosphatases—resting versus preacti-
vated T lymphocytes differ in the kinetics and strength of IKK
activation and, therefore, exhibit differential sensitivities toward
TCR stimulation.
Negative regulation of the NF-kB activating signaling appa-
ratus in lymphocytes is mediated by several control elementsImmunity 37, 697–708, October 19, 2012 ª2012 Elsevier Inc. 705
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IKK Suppression by PP4R1-Driven Dephosphorylationthat operate on distinct levels within the NF-kB pathway (Acuto
et al., 2008; Hymowitz and Wertz, 2010; Vallabhapurapu and
Karin, 2009). The role of phosphatases in NF-kB signaling is
not yet precisely defined. Recently, several studies demon-
strated the selective involvement of different phosphatase enti-
ties in NF-kB inhibition and dephosphorylation of specific phos-
phosubstrates, such as PP2Ac, PP1, and WIP1 (Chew et al.,
2009; Eitelhuber et al., 2011; Li et al., 2006, 2008). However, in
part contradictory results among different approaches already
suggested cell type- and pathway-specific patterns of expres-
sion and/or activity of individual phosphatase components (Li
et al., 2006, 2008). Indeed, in contrast to a previous study (Li
et al., 2008), knockdown of PP1c did not affect IKK phosphory-
lation and activity in T cells (data not shown). Furthermore, given
the potential phosphosubstrate specificity of individual phos-
phatase modules, our data do not contradict previous findings
but rather imply a nonredundant role of different phosphatase
complexes in dephosphorylating distinct target proteins, such
as Carma1, TRAF proteins, RelA, or the IKK complex itself.
PP4R1 is a noncatalytic, regulatory subunit that stably and
specifically associates with the PP4 catalytically active subunit
PP4c, but not with the structurally-related subunit PP2Ac (Ging-
ras et al., 2005; Kloeker and Wadzinski, 1999). Besides PP4R1,
a number of different PP4 regulatory proteins have been
described that give rise to a wide collection of PP4 holoenzymes
with different subcellular distributions, substrate specificities,
and molecular functions, such as DNA damage repair or micro-
tubule organization (Brewis et al., 1993; Chowdhury et al., 2008;
Gingras et al., 2005; Lee et al., 2010). Consistent with the
pleiotropic roles of PP4c, the genetic ablation of PP4c results
in embryonic lethality of mice, and T cell-specific PP4c gene
deletion causes abnormal thymic development and pre-TCR
signaling (Shui et al., 2007). The molecular functions of different
PP4R subunits are largely elusive and have been best defined for
ternary PP4c-PP4R2-PP4R3 complexes that have been recently
implicated in DNA damage repair (Chowdhury et al., 2008; Lee
et al., 2010). In accordance with the concept of modular PP4c
activity, we have identified a distinct PP4c-PP4R1 complex as
a negative regulator of NF-kB signaling in T lymphocytes.
The fact that previous studies have rather linked PP4c to posi-
tive regulation of NF-kB activity (Li et al., 2006; Yeh et al., 2004)
may be explained by ambivalent signaling functions of PP4c that
are most likely determined by the coaction of different regulatory
subunits; for example, PP4c has been shown to directly target
NF-kB subunits downstream of the IKK complex (Yeh et al.,
2004). Pleiotropic and counteracting functions of PP4c might
mask and superimpose separate PP4c signaling roles and,
therefore, complicate its functional analysis.
CTCL represents a clinically heterogeneous group of primarily
skin-residing lymphomas among which MF and SS are the most
common entities. SS is the prototypic variant of an aggressive
skin-homing leukemia that often transformed from a MF stage
(Hwang et al., 2008). A growing body of evidence has established
a key role of NF-kB in CTCL progression and survival. Recent
reports demonstrated constitutive activation of the canonical
NF-kB pathway in the CTCL cell lines SeAx, MyLa, Hut78, and
HH, as well as in malignant peripheral blood T lymphocytes
from patients with SS (so called Se´zary cells) (Sors et al.,
2006). Consistently, we observed an NF-kB-specific target706 Immunity 37, 697–708, October 19, 2012 ª2012 Elsevier Inc.gene expression signature for the CTCL lines SeAx, Hut78, and
HH in comparison to Jurkat T cells. Constitutive activation of
the NF-kB pathway does not seem to be a paraneoplastic event
but is indispensable for the continued proliferation and survival of
CTCL cells in vitro and in vivo (Kiessling et al., 2009). The depen-
dence of CTCL cells on chronic NF-kB signaling for survival
reflects a general phenomenon of oncogenesis, known as onco-
genic addiction (Staudt, 2010). The NF-kB-addicted malignant
phenotype has also been reported for other lymphoid malignan-
cies, such as ABC-DLBCL or Hodgkin’s lymphoma for which
a number of dominant active, oncogenic mutations for compo-
nents of the BCR-induced NF-kB pathway as well as inactivating
mutations of the negative regulator A20 have been identified,
causing constitutive, ligand-independent NF-kB activity (Com-
pagno et al., 2009; Lenz et al., 2008; Staudt, 2010). In contrast,
the molecular etiology underlying constitutive NF-kB signaling
in CTCL cells remains largely unknown (Kim et al., 2000). Here
we report significant downregulation of PP4R1 expression in
a fraction of CTCL cell lines and primary CTCL cells from SS
patients, indicating a role of PP4R1 as a suppressor of onco-
genic NF-kB in CTCL. Indeed, PP4R1 deficiency correlated
with constitutive IKKb activity in PP4R1-deficient CTCL cells.
Forced re-expression of PP4R1 in HH cells reversed constitutive
IKK activation and NF-kB signaling, indicating that PP4R1
deficiency may promote IKK hyperactivation in these cells.
Moreover, reconstitution of PP4R1 expression decreased the
abundance of HH cells, demonstrating that PP4R1 deficiency
unleashes IKK activity and promotes oncogenic NF-kB sig-
naling. However, we do not exclude the possibility that PP4R1
deficiency is a necessary rather than sufficient prerequisite for
dysregulated IKK/NF-kB signaling in these cell and additional
molecular lesions may contribute to the aberrant NF-kB sig-
naling phenotype (Kiessling et al., 2011; Kim et al., 2000). More-
over, the observed effect of PP4R1 re-expression on CTCL
abundance may be attributed to pleiotropic functions culmi-
nating in increased cell death, decreased proliferative capacity,
and/or metabolic disadvantages compared to PP4R1-deficient
cells.
Collectively, our results provide genetic, biochemical, and
functional evidence for PP4R1 as a physiological suppressor of
the NF-kB pathway in T lymphocytes. PP4R1 acts as a regulator
of IKK activity, and PP4R1 deficiency results in deregulated IKK/
NF-kB signaling as well as T cell hyperactivation and is required
for the maintenance of the malignant phenotype of a subset of
CTCL cells.
EXPERIMENTAL PROCEDURES
siRNA Library and NF-kB Reporter Cells
For RNAi screening, a subgenomic, commercially available siRNA library
targeting 298 known or putative phosphatase genes was used (Applied
Biosystems). The library contained three single, independent siRNA oligos
per gene, yielding a total of 894 phosphatase-specific siRNAs. Each individual
siRNA was rearrayed in a 96-well plate format and transfected in duplicate.
G-Luc Jurkat cells were generated by stably integrating a Gaussia luciferase
reporter cassette under the control of 8 3 NF-kB sites into the Jurkat T cell
clone J16-145.
RNAi Screening Procedure
Large scale siRNA transfection of G-Luc Jurkat cells was performed by nucle-
ofection using a 96-well shuttle system (Lonza) according to themanufactures’
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negative control siRNAs encompassing oligos specific for CYLD, RelA,
Carma1, and TNF-R1 as well as nontargeting siRNA and mock transfections
(H2O) were included. Seventy-two hr posttransfection cells were either left
untreated or were stimulated using anti-CD3 (OKT3)/anti-CD28/goat anti-
mouse antibodies (0.1 mg/ml each) or recombinant TNF-a (20 ng/ml). Five hr
poststimulation Gaussia activity was measured in the cell culture supernatant
using a 96-well injection luminometer (Berthold Detection Systems) and
normalized to cell viability using the Celltiter-Glo assay (Promega). All
measurements were performed in duplicate.
Retroviral and Lentiviral Transductions
Retroviral supernatants were prepared by transfection of pMX IRES-GFP
expression vectors into amphotropic Phoenix cells (Swift et al., 2001). For
production of lentiviral particles, HEK293T cells, pretreated with 25 mM chlor-
oquin for 1 hr, were transfected with TRC-derived shRNA vectors and a
plasmid mixture for gag, pol, env and VSV-G for pseudotyping. Eight hr post
transfection medium was replaced from packaging cells. After 2 days, super-
natant was passed through a 0.45 mM filter, supplemented with Polybrene
(8 mg/ml). Target cells (1 3 105 cells) were infected by spin occulation with
1.0 ml of viral supernatant. Stable integrants were selected by puromycin
resistance (1 mg/ml puromycin).
Retroviral Reconstitution Assays
The toxicity of ectopic phosphatase expression was examined by retroviral
reconstitution of the CTCL lines SeAx, MyLa, Hut78, and HH. For the reconsti-
tution assay, CTCL cell lines were retrovirally transduced with pMX-IRES GFP
vectors either expressing GFP alone (ctrl) or coexpressing WT human PP4R1,
PP4c, or PP2Ac. The frequency of GFP-positive cells was monitored over time
by flow cytometry. For a single assay, cells were transduced and analyzed in
triplicate. The percentage of phosphatase-reconstituted cells was normalized
to that of control-transduced cells at the same day. In addition, the ratio of
GFP-positive cells at various time points was normalized to the initial ratio at
day 3–5 posttransduction.
Reverse Transcriptase PCR and Quantitative Real-Time PCR
Total cellular RNA was isolated using the RNAqueous-Micro Kit (Applied
Biosystems). Total RNA (0.5–1.0 mg) was reverse-transcribed with a reverse
transcription (RT)-PCRkit (AppliedBiosystems).QuantitativeRT-PCRwasper-
formed with Power SYBR Green PCR Master Mix (Applied Biosystems). Gene
expression was analyzed using the 7.500 Real-Time PCR Systems and
Sequence Detection Software version 2.0.1 (Applied Biosystems). For some
experiments, Univeral Probe Libray (UPL) assays were designed and quantita-
tive RT-PCR was performed using the ProbesMaster Kit and the LightCycler
480 System (Roche). Relative expression was determined from cycle threshold
(Ct) values andwas normalized using hypoxanthine phosphoribosyltransferase
1 (HPRT1) and/or glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as
reference genes. Sequences of qPCR primers are available upon request.
Cell Culture, Transfections, and Reporter Assays
Humanperipheral T cells were prepared and cultivated asdescribedpreviously
(Peter et al., 1997). For transient reporter assays, 13 107 Jurkat T cells or 23
105 293T cells were cotransfected with p33AP-1-Luc and pfos-LacZ or
pGL83NF-kB-fos and pfos-LacZ as described previously (Arnold et al.,
2001). Transfection efficiency was normalized to LacZ expression. Values
representmean and SDof triplicatemeasurements. HEK293T cells were trans-
fected byCa2+-phosphate coprecipitation using 3–10 mg of plasmid DNA. After
48 hr, cells were lysed in lysis buffer (30 mM Tris/HCl, pH 7.5, 150 mM NaCl,
2 mM EDTA, 1 mM PMSF, protease inhibitor cocktail [Roche], 1% Triton
X-100 (Serva), and 10% glycerol). For transient reporter assays, 13 107 Jurkat
T cells were transfected by electroporation (250V, 950 mF) in 400 ml of IMDM
media using 10–30 mg plasmid DNA. For siRNA and cDNA transfections,
primary human T cells or Jurkat T cells were transfected by nucleofection
(Lonza). For nucleofection, 2 to 53 106 cells were transfectedwith 1 mMsiRNA.
Immunoprecipitation, Immunoblotting, and In Vitro Kinase Assays
Cells were lysed using 1% NP-40 in 20 mM Tris pH 7.4 and 150 mM NaCl
supplemented with protease and phosphatase inhibitors. Two microgramsof antibody coupled to Protein A sepharose was used to immunoprecipitate
proteins from cell lysates for 2–18 hr at 4C. Proteins were resolved by SDS-
PAGE, transferred to Hybond nitrocellulose membrane (Amersham Pharmacia
Biotech) and processed according to the manufacturer’s protocol. In vitro
kinase assays were performed as described previously (Brenner et al.,
2005). Horseradish peroxidase (HRPO)-conjugated antibodies (Abs) were
purchased from Southern Biotechnology Associates. The Abs used were
anti-PP4R1, and anti-PP4c (all from Bethyl), anti-PP2Ac (Thermo Scientific),
anti-FLAG (M2, Sigma), anti-HA (3F10, Roche), anti-Erk, anti-b-actin (Sigma),
anti-IKKg (FL-419), and anti-PP1c (4G3) (all from Santa Cruz), anti-phospho-
Erk (BD Biosciences), anti-Carma1 (ProSci), anti-IKKb (Imgenex), anti-IKKa,
and anti-phospho-IKKa/b (Cell Signaling).
Patient Data
CTCL was diagnosed according to the WHO-EORTC classification of cuta-
neous lymphomas and the criteria of the International Society of Cutaneous
Lymphomas. This study includes patients with MF and SS seen at Mannheim
University Medical Centre and the University Hospital Cologne and was
performed in accordance with the ethical guidelines of the German Cancer
Research Center (DKFZ, Heidelberg) and with the provisions of the Helsinki
protocol. Patients signed the institutional consent forms for use of tissue for
research. In total, 32 CTCL patients were included for analysis of PP4R1
expression by qPCR (n = 12), immunoblot analysis (n = 12), or IHC analysis
of skin biopsies (n = 8).
Statistical Analysis
Mean and SD for all quantitative measurements are representative of triplicate
measurements. In order to examine statistical significance the Student’s t test
(independent two-sample t test, unequal variance) was used. A p value < 0.05
was considered as statistically significant. Overall, the level of statistical
significance was defined as follows: *p < 0.05; **p < 0.01; ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, four tables, and Supple-
mental Experimental Procedures and can be found with this article online at
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